CRISPR-mediated knockdown of LGALS1 in zebrafish transplanted with GBM cells reduced M2-associated gene expression (e.g., arg1 and il10) by 55% and impaired angiogenesis by 40%, highlighting LGALS1 as a potential immunomodulatory target [52]. The gene discussed is LGALS1; the disease is glioblastoma.